Email

weborders@prabadincorp.com

Call us

+1 (786)-332-3938

  • Home
  • Blog
  • Latest Post
  • Product Catalog
b77e8639-129a-40c6-b128-527621a55c3a (1)
994: When can octreotide be discontinued in patients with variceal bleeding?
Health
  • January 23, 2025
By AdminPrabadin - 7 months ago
0

Show notes at pharmacyjoe.com/episode994.

In this episode, I’ll discuss when octreotide can be discontinued in patients with variceal bleeding.

The post 994: When can octreotide be discontinued in patients with variceal bleeding? appeared first on Pharmacy Joe.

Previous article

HPC chip demand to boom for another 4 years

Next article

Sharp’s recovery hinges on CEO-led ‘I-Pro’ initiative with 2 key teams

AdminPrabadin
administrator

Related Articles

Health

Tremelimumab–Durvalumab Combo Extends Survival and Improves Cost-Effectiveness Over…

  • August 16, 2025
Health

Trastuzumab and HER2-Targeted Therapy: Breaking Down the Basics

  • August 15, 2025
Health

Study Finds Widespread Gaps in Knowledge About HPV…

  • August 15, 2025
© Copyright Barta 2018. Designed and Developed by Komarca Soft